- Acumen Powered by Robins Kaplan LLP®
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
September 10, 2024Robins Kaplan Ranks Among Top Firms In 2024 American Lawyer Mid-Level Associates Survey
-
September 9, 2024Federal Judge Orders Transformative Reforms at West LA VA Campus in Major Victory for Disabled Veterans
-
September 9, 2024Robins Kaplan Partners Named to 2025 Lawdragon 500 Leading Litigators in America Guide
-
September 17, 2024Hot Torts:
-
September 18, 202422nd Annual Golf Tournament
-
September 19, 2024Best Practices in Institutionalizing Funding within the Law Firm
-
August 2024Recruiting & Retaining Diverse Attorneys: Building an Inclusive Legal Profession
-
August 22, 2024Prior Art Takeaways From Fed. Circ. Public Disclosure Ruling
-
August 13, 2024Playing Dungeons & Dragons Makes Me A Better Lawyer
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
ANDA Approvals
Summer 2012
| Approval Date | Reference Listed Drug | Generic Drug Name | NDA Holder | ANDA Applicant |
|---|---|---|---|---|
| 4/2/2012 | Lexapro | Escitalopram Oxalate | Forest Labs | Aurobindo Pharma |
| 4/2/2012 | Viorele | Ethinyl Estradiol and Desogestrel | Merck | Glenmark Generics |
| 4/3/2012 | Percocet | Oxycodone and Acetaminophen | Endo Pharms | Actavis Totowa |
| 4/3/2012 | Labetalol Hydrochloride | Labetalol Hydrochloride | Hospira | Gland Pharma |
| 4/3/2012 | Valtrex | Valacyclovir Hydrocholoride | GlaxoSmithKline | Jubilant Organosys |
| 4/6/2012 | Aldara | Imiquimod | Medicis | Apotex |
| 4/6/2012 | Vfrend | Voriconazole | Pfizer | Teva Pharms |
| 4/6/2012 | Keppra | Levetiracetam | UCB Inc | Hospira |
| 4/9/2012 | Vancocin Hydrochloride | Vancomycin Hydrochloride | ViroPharma | Akorn |
| 4/9/2012 | Vancocin Hydrochloride | Vancomycin Hydrochloride | ViroPharma | Strides Arcolab |
| 4/9/2012 | Vancocin Hydrochloride | Vancomycin Hydrochloride | ViroPharma | Watson Labs |
| 4/11/2012 | Keppra | Levetiracetam | UCB | Vintage Pharms |
| 4/11/2012 | Lescol | Fluvastatin Sodium | Novartis | Mylan |
| 4/11/2012 | Norco | Hydrocodone Bitartrate and Acetaminophen | Watson Labs | Aurolife Pharma |
| 4/12/2012 | DDAVP | Desmopressin Acetate | Sanofi Aventis US | Sun Pharm Inds |
| 4/13/2012 | N/A | Amino Acids | N/A | B Braun |
| 4/13/2012 | Antivert | Meclizine Hydrochloride | Pfizer | Epic Pharma |
| 4/13/2012 | Norvasc | Amlodipine Besylate | Pfizer | Macleods Pharms |
| 4/18/2012 | Cisplatin | Cisplatin | App Pharms | Onco Therapies |
| 4/19/2012 | Clarinex | Desloratadine | Schering Plough | Belcher Pharms |
| 4/19/2012 | Femara | Letrozole | Novartis Pharms | Apotex |
| 4/20/2012 | Calan SR | Verapamil Hydrochloride | Pfizer | Apotex |
| 4/23/2012 | Zyprexa | Olanzapine | Lilly | Dr Reddys Labs |
| 4/23/2012 | Zyprexa | Olanzapine | Lilly | Mylan |
| 4/23/2012 | Zyprexa | Olanzapine | Lilly | Apotex |
| 4/23/2012 | Zyprexa | Olanzapine | Lilly | Sun Pharm Inds |
| 4/23/2012 | Zyprexa | Olanzapine | Lilly | Torrent Pharms |
| 4/23/2012 | Zyprexa | Olanzapine | Lilly | Aurobindo Pharma |
| 4/23/2012 | Zyprexa | Olanzapine | Lilly | Orchid Hlthcare |
| 4/30/2012 | Boniva | Ibandronate Sodium | Hoffmann La Roche | Dr Reddys Labs |
| 4/30/2012 | Mirapex | Pramipexole Dihydrochloride | Boehringer Ingelheim | Apotex |
| 4/30/2012 | Amerge | Naratriptan | GlaxoSmithKline | Orchid Hlthcare |
| 4/30/2012 | Tindamax | Tinidazole | Mission Pharma | Roxane |
| 4/30/2012 | Tindamax | Tinidazole | Mission Pharma | Novel Labs |
| 5/1/2012 | Neurontin | Gabapentin | Parke Davis | Kiel |
| 5/1/2012 | Depo-Testosterone | Testosterone Cypionate | Pharmacia and Upjohn | Hikma Farmaceutica |
| 5/2/2012 | Protonix | Pantoprazole Sodium | Wyeth | Apotex |
| 5/2/2012 | Protonix | Pantoprazole Sodium | Wyeth | Ranbaxy Labs |
| 5/3/2012 | Lexapro | Escitalopram Oxalate | Forest Labs | Taro |
| 5/3/2012 | Levitra | Vardenafil Hydrochloride | Bayer Hlthcare | Teva Pharms |
| 5/4/2012 | Lamictal | Lamotrigine | GlaxoSmithKline | Glenmark Generics |
| 5/9/2012 | Acetazolamide Sodium | Acetazolamide Sodium | X Gen Pharms | Sagent Strides |
| 5/10/2012 | Stalevo 100 | Carbidopa, Levodopa and Entacapone | Orion Pharma | Sun Pharma Global |
| 5/11/2012 | MS Contin | Morphine Sulfate | Purdue Pharma | Ranbaxy Labs |
| 5/11/2012 | Zyrtec | Cetirizine Hydrochloride | McNeil Consumer | Silarx |
| 5/11/2012 | Arimidex | Anastrozole | Astrazeneca | Apotex |
| 5/15/2012 | Combivir | Lamivudine and Zidovudine | VIIV Hlthcare | Lupin |
| 5/15/2012 | Combivir | Lamivudine and Zidovudine | VIIV Hlthcare | Aurobindo Pharma |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Apotex |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Teva |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Mylan |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Roxane |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Sun Pharma Global |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Aurobindo Pharma |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Teva |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Torrent Pharms |
| 5/17/2012 | Requip XL | Ropinirole Hydrochloride | SmithKline Beecham | Actavis |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Dr Reddys Labs |
| 5/17/2012 | Plavix | Clopidogrel Bisulfate | Sanofi Aventis US | Gate Pharms |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Aurobindo |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Aurobindo |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Cipla |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Strides |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Hetero Labs Ltd III |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Prinston |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Mylan |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Mylan |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Apotex |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Micro Labs |
| 5/22/2012 | Viramune | Nevirapine | Boehringer Ingelheim | Sciegen Pharms |
| 5/23/2012 | Astelin | Azelastine Hydrochloride | Meda Pharms | Sun Pharma Global |
| 5/23/2012 | Ortho Cyclen-28 | Mono-Linyah | Janssen Pharms | Novast Labs |
| 5/23/2012 | Ovide | Malathion | Taro Pharms North | Suven Life |
| 5/25/2012 | Keppra XR | Levetiracetam | UCB Inc | Boca Pharma |
| 5/29/2012 | Lipitor | Atorvastatin Calcium | Pfizer | Sandoz |
| 5/29/2012 | Lipitor | Atorvastatin Calcium | Pfizer | Teva Pharms |
| 5/29/2012 | Lipitor | Atorvastatin Calcium | Pfizer | Apotex |
| 5/29/2012 | Lipitor | Atorvastatin Calcium | Pfizer | Mylan |
| 5/29/2012 | Keppra XR | Levetiracetam | UCB Inc | Torrent Pharms |
| 5/29/2012 | Carboplatin | Carboplatin | Watson Labs | Onco Therapies |
| 5/30/2012 | Ortho Tri-Cyclen | Tri-Linyah | Janssen Pharms | Novast Labs |
| 5/30/2012 | Vfend | Voriconazole | Pfizer | Sandoz |
| 5/30/2012 | Dovonex | Calcipotriene | Leo Pharma AS | Tolmar |
| 5/30/2012 | Cozaar | Losartan Potassium | Merck | Macleods Pharms |
| 5/31/2012 | Arimidex | Anastrozole | Astrazeneca | Impax Labs |
| 5/31/2012 | Cleocin Phosphate in Dextrose 5% in Plastic Container | Clindamycin Phosphate in 5% Dexytrose in Plastic Container | Pharmacia and Upjohn | Sandoz |
| 5/31/2012 | Optivar | Azelastine Hydrochloride | Meda Pharms | Alcon Pharma |
| 5/31/2012 | Amerge | Naratriptan | GlaxoSmithKline | Mylan |
| 6/1/2012 | Geodon | Ziprasidone Hydrochloride | Pfizer | Sandoz |
| 6/1/2012 | Phoslo Gelgaps | Calcium Acetate | Fresenius Medcl | Paddock |
| 6/1/2012 | Nuvigil | Armodafinil | Cephalon | Mylan |
| 6/6/2012 | Requip XL | Ropinirole Hydrochloride | SmithKline Beecham | Watson Labs |
| 6/6/2012 | Requip XL | Ropinirole Hydrochloride | SmithKline Beecham | Sandoz |
| 6/6/2012 | Requip XL | Ropinirole Hydrochloride | SmithKline Beecham | Dr Reddys Labs |
| 6/8/2012 | Doxycycline | Doxycycline | Par Pharm | Mylan |
| 6/12/2012 | Lescol | Fluvastatin Sodium | Novartis | Teva |
| 6/12/2012 | Exelon | Rivastigmine Tartrate | Novartis | Alembic Pharms |
| 6/12/2012 | Lexapro | Escitalopram Oxalate | Forest Labs | Hetero Labs Ltd III |
| 6/14/2012 | Differin | Adapalene | Galderma Labs LP | Tolmar |
| 6/15/2012 | Zofran & Zofran Preservative Free | Ondansetron Hydrochloride | GlaxoSmithKline | Gland Pharma |
| 6/15/2012 | Theophylline | Theophylline | Silarx | Tris Pharma |
| 6/18/2012 | Vancocin Hydrochloride | Vancomycin Hydrochloride | Viropharma | App Pharms |
| 6/18/2012 | Ziagen | Abacavir Sulfate | VIIV Hlthcare | Mylan |
| 6/19/2012 | Symbyax | Olanzapine and Fluoxetine Hydrochloride | Lilly | Teva |
| 6/20/2012 | Amidate | Etomidate | Hospira | Mylan |
| 6/22/2012 | Adderall XR 30 | Dextroamp Saccharate, AMP Aspartate, Dextroamp Sulfate and AMP Sulfate | Shire | Actavis Elizabeth |
| 6/25/2012 | Thiamine Hydrochloride | Thiamine Hydrochloride | App Pharms | Mylan |
| 6/26/2012 | Actoplus Met | Pioglitazone Hydrochloride and Metformin Hydrochloride | Takeda Global | Mylan |
| 6/26/2012 | Duac | Clindamycin Phosphate; Benzoyl Peroxide | Stiefel | Perrigo Israel |
| 6/27/2012 | Ryzolt | Tramadol Hydrochloride | Purdue Pharma LP | Actavis S Atlantic |
| 6/27/2012 | Ryzolt | Tramadol Hydrochloride | Purdue Pharma LP | Anchen Pharms |
| 6/27/2012 | Zyvox | Linezolid | Pharmacia and Upjohn | Teva |
| 6/27/2012 | Vistide | Cidofovir | Gilead Sciences Inc. | Mylan |
| 6/28/2012 | Promethazine Plain | Promethazine Hydrochloride | Wockhardt | Tris Pharma |
| 6/28/2012 | Prometh W/ Dextromethorphan | Dextromethorphan Hydrobromide; Promethazine Hydrochloride | Actavis Mid Atlantic | Tris Pharma |
| 6/29/2012 | Amaryl | Glimepiride | Sanofi Aventis US | Micro Labs USA |
| 6/29/2012 | Xyzal | Levocetirizine Dihydrochloride | UCB Inc | Hetero Labs LTD III |
| 06/29/201 | Tussionex Pennkinetic | Chlorpheniramine Polistirex; Hydrocodone Polistirex | UCB Inc | Cornerstone Therapies |
GENERICally Speaking Summer 2012
Related Publications
Second Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
June 25, 2024
Amarin Pharma, Inc. v. Hikma Pharms. USA Inc.
GENERICally Speaking Hatch Waxman Bulletin
June 10, 2024
Teva Branded Pharm. Products R&D, Inc. v. Amneal Pharms. of NY, LLC
GENERICally Speaking Hatch Waxman Bulletin
April 30, 2024
Pharmacyclics LLC v. Alvogen Pine Brook LLC
GENERICally Speaking Hatch Waxman Bulletin
First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.